We are proud to announce that OYSTA has been honored with the prestigious iF Design Award for its excellence in digital innovation and user-centric design.
This award is a testament to our shared vision and collaborative efforts of our partners—global life science company OnDosis AB and global technology consultancy Star—to redefine medication management for ADHD and beyond.
Improving ADHD care with digital innovation
OYSTA is more than a product—it’s a transformative solution designed to support medication adherence and enhance the care experience for young patients. By combining pharmaceutical expertise with e-health technology, OYSTA integrates two key components: the OYSTA Dosage Manager and the OYSTA Digital Service. Together, they enable intuitive, precise and flexible dosing, while providing connected care for patients, healthcare providers, teachers and carers.
The OYSTA Digital Service empowers effective ADHD management through tools for medication adherence, real-time data tracking and personalized insights. This breakthrough in personalized medication management improves the treatment experience for young patients and their circle of care.
A collaborative achievement setting a new standard in digital health
This transformative solution was made possible through the collaboration of OnDosis, who led its development, Tiefenbacher Group, which contributed its pharmaceutical expertise, and Star, which designed and built the OYSTA Digital Service—ensuring seamless integration between the physical dosing device and the digital ecosystem.
ADHD treatment is a complex, highly individualized process that requires precise dosage adjustments and continuous monitoring. OYSTA exemplifies an innovative healthcare solution that not only meets medical and technical standards. It also prioritizes the needs of patients and healthcare providers. This milestone reflects our collective dedication to creating a patient-centric solution that sets a new standard in digital health—one that is both effective and accessible.
For more information about OYSTA, visit oysta-health.com.
Explore the work of our partners OnDosis at https://www.ondosis.com/ and Star at star.global
TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).
For more information about our finished dosage forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com
